Cardiovascular Devices Market Projections 2027 | Abbott Laboratories, Biosense Webster, Boston Scientific Corporation, Medtronic plc

Cardiovascular Devices Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

The cardiovascular devices market is expected to exceed owing to the high adoption of innovative devices with growing disease prevalence. Numerous initiatives are being taken by the government to expand existing healthcare infrastructure. While fundings are been made to accelerate R&D activities in the field of cardiovascular medicine. Rising hospital admissions for heart stroke and growing geriatric population base can offer multiple opportunities to cardiovascular device manufacturers.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4949

Increasing geriatric population along with the adoption of unhealthy routine habits worldwide may lead to surge in number of patients suffering from cardiac procedures. The mounting demand for minimally invasive procedures that offer plentiful benefits will create the necessity for advanced cardiovascular devices.

According to the National Institute of Aging, people aged around 65 years and older are at higher risk of sudden heart attack, coronary heart diseases, and strokes. Growing success rates, improved outcomes, and patient satisfaction connected with the use of technologically advanced devices in comparison with drug therapy for such patients will thus lead to rapid product adoption for faster patient recovery. A large number of patients are now adopting advanced treatment procedures.

Rising technological advancements and novel product launches in cardiovascular devices will also play a major role in boosting industry scenario. The need to optimize lesion formation by using ablation catheters with contact force-sensing has boosted product adoption. Major industry players are developing products that meet consumer’s preference towards slightly invasive cardiovascular measures whilst improving efficiency and offering effective treatment outcomes. For instance, the U.S. FDA has approved Boston Scientific Corporation’s new device that is used on patients with non-valvular atrial fibrillation to reduce the risk of stroke.

As per a report published by Global Market Insights, the Germany cardiovascular devices market is expected to witness a 16.9% CAGR during the forecast period. Rising geriatric population base will be a major contributing factor to the country’s national disease burden. The national economy is currently focusing on developing healthcare infrastructure facilities due to the current pandemic situation. Additionally, there is a growing focus by major regional manufacturers on new product development that is expected to bolster the growth of Germany cardiovascular devices market in the coming years.

Request for customization @ https://www.gminsights.com/roc/4949

Some of the prominent players functioning in the global cardiovascular devices industry include Boston Scientific Corporation, Biosense Webster (Johnson & Johnson), Medtronic plc, Abbott Laboratories (St. Jude Medical), and other players. Market players are executing various strategies including product innovations and partnerships to gain a notable presence in the industry.

Partial Chapter of the Table of Content

Chapter 4 Cardiovascular Devices Market, By Device Type

4.1 Key segment trends

4.2 Cardiac ablation devices

4.2.1 Market size, by region, 2016-2027 (USD Million)

4.2.2 Radiofrequency ablators

4.2.2.1 Market size, by region, 2016-2027 (USD Million)

4.2.3 Electric ablators

4.2.3.1 Market size, by region, 2016-2027 (USD Million)

4.2.4 Cryoablation devices

4.2.4.1 Market size, by region, 2016-2027 (USD Million)

4.2.5 Ultrasound devices

4.2.5.1 Market size, by region, 2016-2027 (USD Million)

4.2.6 Others

4.2.6.1 Market size, by region, 2016-2027 (USD Million)

4.3 Left atrial appendage closure devices

4.3.1 Market size, by region, 2016-2027 (USD Million)

4.3.2 Endocardial LAA closure devices

4.3.2.1 Market size, by region, 2016-2027 (USD Million)

4.3.3 Epicardial LAA closure devices

4.3.3.1 Market size, by region, 2016-2027 (USD Million)

4.4 Endoscopic vessel harvesting devices

4.4.1 Market size, by region, 2016-2027 (USD Million)

4.4.2 EVH systems

4.4.2.1 Market size, by region, 2016-2027 (USD Million)

4.4.3 Endoscopes

4.4.3.1 Market size, by region, 2016-2027 (USD Million)

4.4.4 Accessories

4.4.4.1 Market size, by region, 2016-2027 (USD Million)

Chapter 5 Cardiovascular Devices Market, By End-use

5.1 Key segment trends

5.2 Hospitals

5.2.1 Market size, by region, 2016-2027 (USD Million)

5.3 Ambulatory surgical centers

5.3.1 Market size, by region, 2016-2027 (USD Million)

5.4 Cardiac centers

5.4.1 Market size, by region, 2016-2027 (USD Million)

5.5 Others

5.5.1 Market size, by region, 2016-2027 (USD Million)

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/cardiovascular-devices-market

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.